New Infant Cardiac Surgery Device Debuts
This new oxygenator offers specialized support for infants undergoing cardiopulmonary bypass.
Updated on Oct. 30, 2026 in Heart Disease
Live Poll
Do you believe investments in specialized pediatric medical technology are a top priority for healthcare?
Eurosets introduced the Trilly Baby, a new oxygenator designed for cardiopulmonary bypass procedures in infants. The device will begin a controlled market release in 14 European surgery centers in early 2027.
Why it matters
This technology was engineered specifically to manage the unique perfusion demands of small infants. It provides a specialized option for surgeons to maintain blood flow and gas exchange during complex pediatric cardiac operations.
The Trilly Baby device is designed to handle flow rates of 0.1 to 1.8 liters per minute for infants. While presented as a solution for specific perfusion demands, long-term performance data remains unknown pending the upcoming clinical introduction.
The players
Eurosets
An Italian medical technology company established in 1991 that specializes in equipment for cardiopulmonary bypass and extracorporeal life support.
The details
The device manages cardiopulmonary bypass through precise flow control and specialized gas exchange performance optimized for small body sizes. It also emphasizes biocompatibility to support infants throughout the duration of a procedure. Eurosets developed this to ensure the hardware meets the distinct physiological requirements of neonates and infants during open-heart surgery.
Timeline
Eurosets was founded in 1991.
The Trilly Baby was presented at Europerfusion 2026 on October 30-31, 2026.
The device is expected to receive a CE mark by the end of 2026.
A controlled market release begins in January 2027.
Health Landscape
The introduction of this oxygenator at the Europerfusion 2026 conference marks a shift toward miniaturized, age-specific cardiac technology. This trend aims to reduce the reliance on adult-sized equipment for the unique physiological needs of infant patients.
Parents of infants requiring cardiac surgery can discuss with their pediatric cardiothoracic surgeon what equipment is best suited for their child's specific needs. Understanding the available technology can help families better navigate the details of upcoming surgical procedures.
The takeaway
Advancements in pediatric-specific perfusion technology aim to improve surgical precision for the smallest patients. Families facing surgery should consult their care team to understand the specific tools and safety features being used during their child's procedure.
Further reading
For more on evolving surgical technologies for cardiac care, visit our Heart Disease section.
More information
View the official press release multimedia for technical product details.
Source note: This article includes information reported by AFP.
Live Poll
Do you believe investments in specialized pediatric medical technology are a top priority for healthcare?
